More than 7 months following the first report of novel coronavirus disease (COVID-19), knowledge of the complications and sequelae of this disease has increased substantially. Through this alert, the ...
PureTech has initiated a Phase 2 trial evaluating LYT-100 as a potential treatment for Long COVID respiratory complications and related sequelae. PureTech also intends to initiate a Phase 2a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results